Team:PennState/smartfold/overview

From 2008.igem.org

(Difference between revisions)
 
(One intermediate revision not shown)
Line 1: Line 1:
<html>
<html>
-
<!--
 
-
  Landing page
 
-
  Contains links to all other pages of the site as well as a quick introduction to the projects
 
-
  The aim of this page was to be visually appealing and contain a very small amount of text so that the user would be given a quick introduction to the project. The  user has only to read several lines to get a good grasp of what we did. This will encourage them to explore deeper.
 
-
-->
 
<head>
<head>
-
<!--
 
-
  Cascading Style Sheet (CSS) component
 
-
  in plain html style sheets are completely independent of the HTML page but are included in this page to simplify design within a wiki script environment.
 
-
  This section describes the layout, colors and images displayed on the page
 
-
-->
 
<style>
<style>
-
 
#globalWrapper {
#globalWrapper {
  background-image: url("https://static.igem.org/mediawiki/2008/e/e4/Bglogo.png") !important;
  background-image: url("https://static.igem.org/mediawiki/2008/e/e4/Bglogo.png") !important;
Line 52: Line 41:
}
}
-
.links td:hover {
+
.links td {
-
background-color: rgb(37,169,113);
+
padding: 0;
}
}
.links a{
.links a{
-
text-decoration:none;
+
display: block;
-
font-size:14px;
+
width: 100%;
-
color: #000;
+
height: 100%;
 +
margin: 0;
 +
text-align: center;
 +
text-decoration: none;
 +
font-size: 14px;
 +
color: #000;
}
}
Line 67: Line 61:
.links a:hover {
.links a:hover {
 +
background-color: rgb(37,169,113);
}
}
-
 
#header {
#header {
Line 120: Line 114:
#pagecontent p {
#pagecontent p {
  text-indent: 1.25em;
  text-indent: 1.25em;
 +
}
 +
 +
p.start:first-line {
 +
font-weight: bold;
}
}
</style>
</style>
Line 135: Line 133:
<table class="links" >
<table class="links" >
   <tr>
   <tr>
-
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState" >Home</a> </td>
+
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState" title="Welcome!">Home</a> </td>
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Team" >The Team</a> </td>
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Team" >The Team</a> </td>
-
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Project" >The Project</a> </td>
+
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Project" title="Full Abstracts.">The Project</a> </td>
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Parts">Parts</a> </td>
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Parts">Parts</a> </td>
-
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Modeling" >Modeling</a> </td>
+
     <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Notebook" title="Day to day lab activity">Notebook</a> </td>
-
    <td align="center" ><a class="mainLinks" href="https://2008.igem.org/Team:PennState/Notebook" >Notebook</a> </td>
+
   </tr>
   </tr>
</table>
</table>
Line 164: Line 161:
  <h4><acronym title="Nuclear Hormone Receptor">NHR Biosensors</acronym><br/></h4>
  <h4><acronym title="Nuclear Hormone Receptor">NHR Biosensors</acronym><br/></h4>
  <dl id="denav">
  <dl id="denav">
-
   <dd><a href="hbintro" title="Intro to Endocrine Disruption, pseudoestrogens, pthalates, nuclear hormone receptors, and our goals">Introduction</a></dd>
+
   <dd><a href="https://2008.igem.org/Team:PennState/NHR/introduction">NHR Introduction</a></dd>
   <dd><a href="https://2008.igem.org/Team:PennState/smartfold/overview">Phthalate Biosensor</a></dd>
   <dd><a href="https://2008.igem.org/Team:PennState/smartfold/overview">Phthalate Biosensor</a></dd>
Line 171: Line 168:
  </dl>
  </dl>
</td>
</td>
-
 
<!-- Main content area -->
<!-- Main content area -->
-
<td valign="top" id="pagecontent">
+
<td valign="top" id="pagecontent" width="80%"><span style="font-size: 16pt">Phthalate Biosensor</span>
-
 
+
<hr/>
-
<h2>Smart Fold Project In Depth</h2>
+
<p class="start">The human PPAR has three different types α, β, and γ but only two show any affect by phthalates. We are using the alpha form which is expressed in the liver, kidney, heart, muscle, adipose tissue, and others. There are different regions associated with nuclear hormone receptors: N-terminal, DNA binding domain (DBD), Hinge, Ligand binding domain (LBD), and C-terminal. The LBD is the region that attracts and holds the ligand of interest. After ligand binding the receptor usually will form a dimer, in our case PPAR will combine with Retinoid X Receptor (RXR) to form a heterodimer. The RXR protein functions much like the PPAR but in this case it does not need to attach a ligand before dimerization. The heterodimer will bind to Peroxisome Proliferator Response Element (PPRE) via the DBD and activates transcription. Most often a coactivator complex is required for transcriptional activation which involves proteins SRC-1, CBP and others.</p>
-
<p>The human <acronym title="Peroxisome Proliferator Activated Receptor">PPAR</acronym> has three different types α, β, and γ but only two show any affect by phthalates. We are using the alpha form which is expressed in the liver, kidney, heart, muscle, adipose tissue, and others. There are different regions associated with nuclear hormone receptors: N-terminal, DNA binding domain (DBD), Hinge, Ligand binding domain (LBD), and C-terminal. The LBD is the region that attracts and holds the ligand of interest. After ligand binding the receptor usually will form a dimer, in our case PPAR will combine with Retinoid X Receptor (RXR) to form a heterodimer. The RXR protein functions much like the PPAR but in this case it does not need to attach a ligand before dimerization. The heterodimer will bind to Peroxisome Proliferator Response Element (PPRE) via the DBD and activates transcription. Most often a coactivator complex is required for transcriptional activation which involves proteins SRC-1, CBP and others.</p>
+
-
<p>This Smart Fold Reporter project uses altered growth conditions so that the entire PPAR protein is successfully expressed and used to transcriptionally report for the presence of phthalates. Expressing the entire PPAR in E. Coli has proven difficult which could be caused by toxicicity to the cells from the DBD. To overcome this problem we are going to treat the E. Coli with carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) which is an uncoupler of oxidative phosphorylation. This strategy would correlate to the heat shock proteins involved with synthesis in the human body. The cells that have the PPAR plasmid will be grown on plates containing Timentin (a combination of Ticarcillin and clavulanic acid) which prevents growth of bacteria without plasmid more strongly than Ampicillin alone. The expression of the PPAR and RXR also need tight regulation so the arabinose operon will be used. A green fluorescent protein will be placed after the PPRE to signal transcription after heterodimer binding.</p>
+
<p class="start">This Smart Fold Reporter project uses altered growth conditions so that the entire PPAR protein is successfully expressed and used to transcriptionally report for the presence of phthalates. Expressing the entire PPAR in E. Coli has proven difficult which could be caused by toxicicity to the cells from the DBD. To overcome this problem we are going to treat the E. Coli with carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) which is an uncoupler of oxidative phosphorylation. This strategy would correlate to the heat shock proteins involved with synthesis in the human body. The cells that have the PPAR plasmid will be grown on plates containing Timentin (a combination of Ticarcillin and clavulanic acid) which prevents growth of bacteria without plasmid more strongly than Ampicillin alone. The expression of the PPAR and RXR also need tight regulation so the arabinose operon will be used. A green fluorescent protein will be placed after the PPRE to signal transcription after heterodimer binding.</p>
-
</td></tr></table>
+
</td></tr></table> <!-- end the table for content quadrants -->
 +
</td></tr></table> <!-- end content block that is adjacent to sidelinks -->
 +
</body>
 +
</html>

Latest revision as of 16:28, 28 October 2008

Diauxie Elimination

Introduction
The System
Strategies
Progress
Conclusions
Parts
References

NHR Biosensors

NHR Introduction
Phthalate Biosensor
BPA Biosensor
Phthalate Biosensor

The human PPAR has three different types α, β, and γ but only two show any affect by phthalates. We are using the alpha form which is expressed in the liver, kidney, heart, muscle, adipose tissue, and others. There are different regions associated with nuclear hormone receptors: N-terminal, DNA binding domain (DBD), Hinge, Ligand binding domain (LBD), and C-terminal. The LBD is the region that attracts and holds the ligand of interest. After ligand binding the receptor usually will form a dimer, in our case PPAR will combine with Retinoid X Receptor (RXR) to form a heterodimer. The RXR protein functions much like the PPAR but in this case it does not need to attach a ligand before dimerization. The heterodimer will bind to Peroxisome Proliferator Response Element (PPRE) via the DBD and activates transcription. Most often a coactivator complex is required for transcriptional activation which involves proteins SRC-1, CBP and others.

This Smart Fold Reporter project uses altered growth conditions so that the entire PPAR protein is successfully expressed and used to transcriptionally report for the presence of phthalates. Expressing the entire PPAR in E. Coli has proven difficult which could be caused by toxicicity to the cells from the DBD. To overcome this problem we are going to treat the E. Coli with carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) which is an uncoupler of oxidative phosphorylation. This strategy would correlate to the heat shock proteins involved with synthesis in the human body. The cells that have the PPAR plasmid will be grown on plates containing Timentin (a combination of Ticarcillin and clavulanic acid) which prevents growth of bacteria without plasmid more strongly than Ampicillin alone. The expression of the PPAR and RXR also need tight regulation so the arabinose operon will be used. A green fluorescent protein will be placed after the PPRE to signal transcription after heterodimer binding.